Correlation Between Onconova Therapeutics and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on Onconova Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and ABVC Biopharma.

Diversification Opportunities for Onconova Therapeutics and ABVC Biopharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Onconova and ABVC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Onconova Therapeutics and ABVC Biopharma

Given the investment horizon of 90 days Onconova Therapeutics is expected to generate 0.9 times more return on investment than ABVC Biopharma. However, Onconova Therapeutics is 1.11 times less risky than ABVC Biopharma. It trades about 0.06 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.03 per unit of risk. If you would invest  76.00  in Onconova Therapeutics on August 29, 2024 and sell it today you would earn a total of  26.00  from holding Onconova Therapeutics or generate 34.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy31.45%
ValuesDaily Returns

Onconova Therapeutics  vs.  ABVC Biopharma

 Performance 
       Timeline  
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Onconova Therapeutics and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Onconova Therapeutics and ABVC Biopharma

The main advantage of trading using opposite Onconova Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Onconova Therapeutics and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.